• Alcon (Huenenberg, Switzerland) reported FDA approval of its aspheric AcrySof IQ Toric intraocular lens (IOL). The new lens offers an enhanced aspheric optic that improves image quality and increases contrast sensitivity in cataract surgery patients with astigmatism. Alcon says that the AcrySof Intraocular lenses are the most frequently implanted lenses in the world, with more than 40 million implants since their introduction in the early 1990s. Alcon's AcrySof IOL platform offers cataract patients a variety of benefits and is available with a variety of optics designed to help patients achieve the best possible vision. The AcrySof family of IOLs includes the AcrySof IQ, AcrySof IQ Toric and AcrySof IQ ReSTOR IOLs.

• Ansys (Southpointe, Pennsylvania) reported the introduction of the @neurIST project, saying it has completed a milestone toward its goal of helping clinicians understand and manage cerebral aneurysms. The project teamed with Ansys to use high-end engineering simulation, which is being increasingly used in the fields of biomedicine and healthcare. The @neurIST project successfully demonstrated its underlying series of linked tools called a "toolchain" using software from Ansys, which automates complex tasks such as aneurysm modeling and simulation. The project is now moving toward developing patient-specific treatment for this devastating condition.

• Cantel Medical (Little Falls, New Jersey) said the FDA has cleared its Medivators Advantage Plus Endoscope Reprocessing System and new Rapicide PA High Level Disinfectant for sale in the U.S. The Advantage Plus System, with its accompanying new chemistry, represents the latest in a long line of "state of the art", innovative reprocessing technologies that Medivators has been delivering to hospitals and stand-alone GI centers for over 20 years.

• Serica Technologies (Medford, Massachusetts) received FDA clearance for its SeriScaffold silk-based, long-term bioresorbable scaffold technology. The company says that the SeriScaffold platform technology provides a natural protein-based alternative to synthetic materials and graft products harvested from human or animal cadaver tissue. "We believe our ... SeriScaffold technology has applications for a wide range of necessary procedures for patients requiring reconstructive plastic surgery, as well as for patients undergoing elective and other forms of soft tissue repair surgery," said President/CEO Gregory Altman.

• Smith & Nephew's Advanced Wound Management division (St. Petersburg, Florida) reported the U.S. launch of its Renasys EZ Negative Pressure Wound Therapy (NPWT) system, which the company says is designed to address the needs of wound care professionals and patients. Smith & Nephew said it designed the Renasys EZ based on customer insights to improve the NPWT experience, focusing on greater ease of use and patient comfort across the full range of wound types. Renasys EZ allows clinicians to use variable pressure control, enables clinicians to treat surgical, traumatic or chronic wounds according to the individual needs of the patient and the characteristics of the patient's wound.

• Southwest Medical Associates (SMA; Las Vegas) has introduced a portable medical record (PMR) designed to give healthcare providers immediate access to their patients' health care information. The PMR is a compact disc that instead of containing the data on the disc has a link to a portal containing a patient's current, vital medical records, which can be accessed in real time by any healthcare provider, including emergency room physicians and staff. The records contain healthcare information including medications and health issues, recent hospital stays, EKG test results, allergies; emergency contact information.

• Teleflex Medical (Research Triangle Park, North Carolina), has introduced the Arrow Pressure Injectable Triple Lumen PICC (Peripherally Inserted Central Catheter). The catheter has a non-tapered body, contoured tip and strong polyurethane construction that softens in situ. The catheter's Blue FlexTip is designed to reduce patients' vessel trauma. The catheter's firmness also maintains patency throughout treatment, as it withstands high-pressure injection procedures. This unique tip design, with its staggered ports, is designed to reduce the risk of medications mixing and forming a precipitate that could obstruct other trimmed catheters. The Arrow Pressure Injectable Triple Lumen PICC is also indicated for central venous pressure monitoring.

No Comments